Drug Interactions between IBgard and perampanel
This report displays the potential drug interactions for the following 2 drugs:
- IBgard (peppermint oil)
- perampanel
Interactions between your drugs
No interactions were found between IBgard and perampanel. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
IBgard
A total of 22 drugs are known to interact with IBgard.
- Ibgard is in the drug class anticholinergics/antispasmodics.
- Ibgard is used to treat the following conditions:
perampanel
A total of 332 drugs are known to interact with perampanel.
- Perampanel is in the drug class AMPA receptor antagonists.
- Perampanel is used to treat the following conditions:
Drug and food/lifestyle interactions
peppermint oil food/lifestyle
Applies to: IBgard (peppermint oil)
ADJUST DOSING INTERVAL: Administration of enteric-coated, gastro-resistant formulations of peppermint oil (e.g., delayed or sustained release capsules) with food may cause premature dissolution of the enteric coating and early release of the peppermint oil, which could lead to gastrointestinal irritation and reduced therapeutic effects.
MANAGEMENT: Enteric-coated, gastro-resistant formulations of peppermint oil should not be taken immediately after eating. These products should preferably be taken 30 to 90 minutes before a meal with water. The labeling for the specific product should be consulted for administration recommendations and other guidance.
References (3)
- (2018) "Product Information. Ibgard (peppermint oil)." IM Helthscience llc, 1
- (2021) "Product Information. Colpermin IBS Relief (peppermint oil)." Kenvue UK Ltd
- (2023) "Product Information. Buscomint (peppermint oil)." Opella Healthcare UK Ltd
perampanel food/lifestyle
Applies to: perampanel
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References (4)
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.